HIMS vs MD
As of Sep 20, 2026, Hims & Hers Health (HIMS) scores 4.4/10 and Pediatrix Medical Group (MD) 6.9/10 on AlphaStocks' five-model composite, so MD scores higher. HIMS trades 131% above its model fair value; MD trades 25% below its model fair value.
HIMS
Hims & Hers Health, Inc.
4.4
Weak
$27.98
MD
Pediatrix Medical Group, Inc.
6.9
Consider Buy
$25.93
HIMS vs MD: Which is the Better Investment?
Hims & Hers Health, Inc. (HIMS) scores 4.4/10 while Pediatrix Medical Group, Inc. (MD) scores 6.9/10 on AlphaStocks' composite model. Pediatrix Medical Group, Inc. has the higher composite rating of Consider Buy. On a P/E basis, Pediatrix Medical Group, Inc. trades at 13.4x, making it the more attractively priced of the two. Pediatrix Medical Group, Inc. trades further below its estimated fair value.
This comparison is algorithmically generated and is not financial advice.
| Metric | HIMS | MD |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 4.4/10 | 6.9/10▲ |
| Rating | Weak | Consider Buy▲ |
| Price | $27.98 | $25.93 |
| P/E Ratio | 56.3 | 13.4▲ |
| ROE | 18.8% | 18.8%▲ |
| Market Cap | $6B | $2B |
| Fair Value | $12.12 | $34.74 |
| Dividend Yield | — | — |
| Sector Rank | #130 of 168 | #17 of 168▲ |
| Model Verdicts | ||
| Piotroski | Neutral | Attractive▲ |
| Buffett | Caution | Attractive▲ |
| Graham | Caution | Caution |
| Lynch | Limited Data | Neutral▲ |
| Greenblatt | Caution | Strong▲ |
Related comparisons
HIMS vs MD: Which Stock Scores Higher?
Hims & Hers Health, Inc. (HIMS) and Pediatrix Medical Group, Inc. (MD) are both in the Health Care sector. MD currently leads with a composite score of 6.9/10 (Consider Buy) compared to HIMS's 4.4/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer